Icon
+91 94997 68112
Login Register

NICODERM CQ (nda020165)- (7MG/24HR,14MG/24HR,21MG/24HR)

NICOTINE CHATTEM SANOFI
7MG/24HR,14MG/24HR,21MG/24HR
No No
2021-May-22 Expired
None None
None No
NICODERM CQ is indicated to reduce the withdrawal symptoms, including nicotine craving, associated with quitting smoking.
1 0 1
Total Other Developers 1
Drugs with Suitability No
7MG/24HR ** ** - 1 -
14MG/24HR ** ** - 1 -
21MG/24HR ** ** - - 1
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ***** **** ******** ******* ***. *********** **** ******** *******, *******, ******* (**) *****, ****** ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.